Novartis Investigative Site

Legnago, VR 37045

1 studies enrolling now · 3 studies all time

What they study most

Acute Decompensated Heart Failure, Asthma, Atherosclerotic Cardiovascular Disease (ASCVD), Congestive Heart Failure

Studies at this site

• Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD — Recruiting now
• Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. — Completed
• Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure — Completed